A. Zaenglein and J. Del Rosso, “An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period”, J of Skin, vol. 2, no. S1, p. S33, Feb. 2018.